STOCKHOLM, Sweden — Esmolol hydrochloride gel (Galnobax, NovoLead) appears to be a safe and effective novel topical treatment option for diabetic foot ulcers, according to results from a new trial of ...
MIAMI, July 22, 2025 /PRNewswire/ -- A newly published, multicenter clinical trial in the Journal of Wound Care presents promising evidence supporting the use of a botanical-based hydrogel for the ...
Pairing esmolol hydrochloride topical gel treatment with standard wound care resulted in significantly greater diabetic foot wound closure compared to standard wound care alone, the results of a ...
Average Percent Area Reduction of 97% in 4 weeks in diabetic wounds 100% diabetic wound closure in ≤ 12 weeks Preclinical ...
Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
Program enables access to R327G for diabetic foot infections (DFI), following recent positive Phase II results in acute bacterial skin and skin-structure infections (ABSSSI), including diabetic foot ...
The researchers from the National University of Singapore (NUS), who engineered the gel, explained that each treatment involves the application of a bandage pre-loaded with a hydrogel containing skin ...
WASHINGTON, June 6 (Reuters) - Johnson & Johnson has added a strong "black box" warning about the risk of dying from cancer to the prescribing instructions for the company's Regranex diabetic foot gel ...
https://www.thehindubusinessline.com/news/national/novalead-to-ink-deal-with-pharma-company-for-its-novel-diabetic-foot-ulcer-gel/article68457411.ece Copy Drug ...
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-healing wounds could cause serious infections resulting in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback